Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (apre una nuova finestra)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Fonte‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Indicizzato‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (apre una nuova finestra)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (apre una nuova finestra)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Fonte‎: Cochrane Database Syst Rev 2018;4:CD011689.

Indicizzato‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (apre una nuova finestra)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (apre una nuova finestra)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Fonte‎: Am J Obstet Gynecol.

Indicizzato‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (apre una nuova finestra)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (apre una nuova finestra)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Fonte‎: S Afr Med J 2016;106(4):399-402.

Indicizzato‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (apre una nuova finestra)

Prophylactic use of ergot alkaloids in the third stage of labour. (apre una nuova finestra)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Fonte‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Indicizzato‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (apre una nuova finestra)

Treatment for primary postpartum haemorrhage. (apre una nuova finestra)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Fonte‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Indicizzato‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (apre una nuova finestra)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (apre una nuova finestra)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Fonte‎: Obstet Gynecol 2001;98(3):386-90.

Indicizzato‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (apre una nuova finestra)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (apre una nuova finestra)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Fonte‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Indicizzato‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (apre una nuova finestra)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (apre una nuova finestra)

Ragab A, Barakat R, Alsammani MA.

Fonte‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Indicizzato‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (apre una nuova finestra)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (apre una nuova finestra)

Roach MK, Abramovici A, Tita AT.

Fonte‎: Am J Perinatol 2013;30(7):523-8.

Indicizzato‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (apre una nuova finestra)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (apre una nuova finestra)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Fonte‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Indicizzato‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (apre una nuova finestra)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (apre una nuova finestra)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Fonte‎: Lancet Glob Health. 2023 11(2):e287-e295.

Indicizzato‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (apre una nuova finestra)

Intravenous sulprostone infusion in the treatment of retained placenta. (apre una nuova finestra)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Fonte‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Indicizzato‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (apre una nuova finestra)

Carbetocin for preventing postpartum haemorrhage. (apre una nuova finestra)

Su LL, Chong YS, Samuel M.

Fonte‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Indicizzato‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (apre una nuova finestra)

Prostaglandins for preventing postpartum haemorrhage. (apre una nuova finestra)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Fonte‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Indicizzato‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (apre una nuova finestra)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (apre una nuova finestra)

Westhoff G, Cotter AM, Tolosa JE.

Fonte‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Indicizzato‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (apre una nuova finestra)